Head of Lead Discovery
Accent Therapeutics, Massachusetts, United States
Shane Buker joined Accent in January 2018 as head of the Lead Discovery group where he leverages biochemical and biophysical techniques to advance small molecule drug discovery programs forward. Prior to Accent he has worked at Goldfinch Bio, Forma Therapeutics and Constellation Pharmaceuticals. He received his B.A. from Boston University and his Ph.D. in biochemistry and molecular pharmacology from Harvard Medical School.
Disclosure information not submitted.
Monday, February 7, 2022
2:00 PM – 2:30 PM